Study of FLUTIFORM [formoterol fumarate/fluticasone propionate] vs Seratide [salmeterol/fluticasone propionate] in paediatric subjects with asthma

Trial Profile

Study of FLUTIFORM [formoterol fumarate/fluticasone propionate] vs Seratide [salmeterol/fluticasone propionate] in paediatric subjects with asthma

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Jul 2012

At a glance

  • Drugs Formoterol/fluticasone propionate; Salmeterol/fluticasone propionate
  • Indications Asthma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 04 Jul 2012 Company added in the association field as reported by EudraCT.
    • 28 Sep 2011 Extension study tolerability results presented at the 21st Annual Congress of the European Respiratory Society.
    • 28 Sep 2011 Results presented at the 21st Annual Congress of the European Respiratory Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top